Is NiceRx an Omnipaque coupon provider?
NiceRx is not an Omnipaque coupon, Omnipaque discount card, or Omnipaque copay card provider. We do not offer Omnipaque manufacturer coupons, Omnipaque discounts, rebates, Omnipaque savings cards, trial offers, or free Omnipaque samples. We are a service provider that helps eligible individuals access their medication directly from the U.S. pharmaceutical company.
Omnipaque patient assistance program
Patient assistance programs are typically sponsored by pharmaceutical companies and provide free or discounted medications to individuals with low income who are uninsured or under-insured and meet the eligibility criteria that vary by program. There are currently no known patient assistance programs for this medication.
Can NiceRx help me get Omnipaque cheaper if I have insurance?
How much does Omnipaque cost without insurance?
Without insurance, Omnipaque costs will vary depending on where you buy the medication as prices will vary by retailer. As a guide, Omnipaque 12 oral solution (12 mg/mL) will cost around $95 for 5000 milliliters.
How much does Omnipaque cost with insurance?
The copay for Omnipaque will depend on the terms of your healthcare plan. Your healthcare provider or pharmacist will be able to calculate your copay with your current insurance. Contact them to find out more.
What is Omnipaque?
Omnipaque is an FDA (U.S. Food and Drug Administration) approved medication manufactured by GE Healthcare. Omnipaque is a radiographic contrast agent used for intrathecal, intravascular, oral, rectal, intraarticular, and body cavity use (X-rays). Omnipaque oral solution is used for oral use only with Omnipaque injection given intravenously for computed tomography (CT scans) of the abdomen.
Omnipaque 140, Omnipaque 180, Omnipaque 240, Omnipaque 300, and Omnipaque 350 have osmolalities from 1.1 to 3.0 times that of plasma or cerebrospinal fluid and are hypertonic under conditions of use.
What doses of Omnipaque are available?
Omnipaque is available as:
- Omnipaque injection – 140 mg of iodine per mL +PlusPak polymer bottles, 180 mg of iodine per mL in glass vials, 240 mg of iodine per mL, 300 mg of iodine per mL, and 350 mg of iodine per mL in glass vials and bottles and +PlusPak polymer bottles
- Omnipaque oral solution – 9 mg of iodine per mL, and 12 mg of iodine per mL in +PlusPak polymer bottles
Omnipaque is given as an intravascular administration. It may cause sickling in patients who are homozygous for sickle cell disease. A total dose of 3060 mg iodine or a concentration of 300 mg/mL should not be exceeded in adults and a total dose of 2700 mg iodine or a concentration of 180 mgI/mL should not be exceeded in children in a single examination.
Your dose for intravenous administration of Omnipaque injection will be based on your age, body weight, vessel size, blood flow within the vessel, expected pathology, the degree and level of opacification required, the area to be examined, your illness, and the equipment and technique to be used. Always speak with a healthcare professional about any changes to your dose so they can monitor and evaluate your condition.
Omnipaque active ingredients
The active ingredient of Omnipaque is iohexol. It is classed as a non-ionic iodinated contrast media.
Omnipaque side effects
The most common side effects of Omnipaque in clinical trials (incidence > 1.0%) include:
- Backache, neckache, stiffness, and neuralgia
- Nausea, vomiting, and dizziness
- Blurred vision and photomas
- Arrhythmias including premature ventricular contractions and premature atrial contractions
- Angina/chest pain
- Diarrhea, abdominal pain, flatulence
- Swelling and heat sensation
- Rash, pruritus, urticaria, and dyspnea
In rare instances, Omnipaque can cause more serious side effects. These can include:
- Life-threatening hypersensitivity reactions
- Contrast-induced acute kidney injury, including renal failure
- Cardiovascular reactions including shock and cardiac arrest
- Thromboembolic events causing myocardial infarction and stroke
- Hyperthyroidism, or hypothyroidism in pediatric patients
- Hypertensive crisis (severely elevated blood pressure) in patients with pheochromocytoma
- Stevens-Johnson syndrome/toxic epidermal necrolysis
- Accidental intrathecal administration may cause death, convulsions, cerebral hemorrhage, coma, paralysis, acute renal failure, rhabdomyolysis, hyperthermia, and brain edema
Your doctor will assess the benefits of using Omnipaque against your risk of adverse effects. Patients are encouraged to report negative side effects or adverse reactions of Omnipaque to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Omnipaque drug interactions
Omnipaque can interact with other medications. These include:
- Iodinated contrast agents increase the risk of metformin-induced lactic acidosis. Stop metformin before and during treatment in patients with an eGFR between 30 and 60 mL/min/1.73 m2, in those patients with hepatic impairment, alcoholism, heart failure, or in patients who will be given intra-arterial iodinated contrast
- Beta-adrenergic blocking agents
- Drugs that lower seizure threshold
- CNS active drugs such as monoamine oxidase (MAO) inhibitors, tricyclic antidepressants, CNS stimulants, major tranquilizers, or antipsychotic drugs should be stopped at least 48 hours before myelography, not used for the control of nausea or vomiting during or after, and not restarted for at least 24 hours after
- Drug laboratory test interactions – the iodine-binding ability of thyroid tissue may be decreased for up to 2 weeks after contrast medium use. Thyroid function tests not dependent on iodine estimation are not affected
This list is not exhaustive and other prescription drugs may interact with Omnipaque.
You should not use Omnipaque if you:
- Are allergic to the active ingredient iohexol
- Are allergic to any of the other ingredients in Omnipaque
- Are intending to use it for intrathecal use
Omnipaque body cavity 240 and 300 for hysterosalpingography should not be used if you:
- Are pregnant or are planning to become pregnant
- Are menstruating or menstruation is imminent
- Are within 6 months of having terminated a pregnancy
- Have signs of an infection in any portion of the genital tract, including the external genitalia
- Have known or suspected reproductive tract neoplasia
Talk to your doctor before using Omnipaque if you:
- Are taking any of the medications that could interact with Omnipaque
- Have renal impairment
- Are dehydrated
- Have diabetes mellitus
- Have congestive heart failure
- Have advanced vascular disease
- Are elderly
- Are breastfeeding or are planning to breastfeed – lactating women should pump and discard breast milk for 10 hours after treatment
Omnipaque is the trademark brand name for iohexol manufactured by GE Healthcare. A generic version of iohexol is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Omnipaque savings through NiceRx.
The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.